ReviewCureus2024
Dr. Indira Nath: Innovator in Leprosy Immunology and a Beacon of Scientific Excellence.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dr. Indira Nath, an Indian immunologist, was born on January 14, 1938 and passed away on October 24, 2021. Dr. Indira Nath is considered one of the pioneers of immunology in India. Immunologists study the role of the immune system in human health and diseases. While many immunologists prefer to study cancers and autoimmune conditions, in contrast, Dr. Indira Nath chose to study the immunology of leprosy, a neglected tropical disease that had a considerable disease burden and social stigma in India. She returned to India and joined her alma mater, where she continued the rest of the journey until her formal retirement. Meanwhile, Dr. Nath also oversaw the establishment of a new department of biotechnology at the All India Institute of Medical Sciences (AIIMS), New Delhi, where she served as the founding head and further advanced her new-age research on the immunology of leprosy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.